Agios Pharmaceuticals, Inc. · NASDAQ:AGIO

Paradigm Biocapital Advisors LP's stake in Agios Pharmaceuticals, Inc. fell to 4.90% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Paradigm Biocapital Advisors LP's stake in Agios Pharmaceuticals, Inc. fell to 4.90%, 2,873,555 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
4.90%
Shares
2,873,555
Intent
Passive
What changed
Fell below 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP4.90%2,873,555
Paradigm BioCapital Advisors GP LLC4.90%2,873,555
Senai Asefaw, M.D.4.90%2,873,555
Paradigm BioCapital International Fund Ltd.4.40%2,536,170

Source

View original at SEC

Related